SeekGene Partners with the Human Cell Atlas (HCA) to Expand Global Access to Single-Cell Multi-Omics Technologies

Release date : Feb 12,2026

Classification : News

 

February 12, 2026 | Beijing, China — SeekGene today announced that it has joined the Human Cell Atlas (HCA) Commercial Discount Program, providing eligible consortium members with exclusive commercial discounts on its single-cell platforms and assays to support large-scale cell atlas research worldwide.

 

The Human Cell Atlas is an international initiative to map every human cell type as a foundation for understanding health and disease. By participating in the program, SeekGene aims to lower cost and technical barriers to integrated single-cell analysis, enabling more research teams to generate consistent, high-quality multi-omics datasets at scale.

 

“The Human Cell Atlas consortium welcomes the participation of technology developers like SeekGene,” said John Randell, Executive Director of the HCA. “Access to advanced and accessible single-cell multi-omics tools is crucial for our global research community to build comprehensive reference maps.”

 

Supporting integrated single-cell multi-omics research

 

Recently launched, the SeekOne™ DD Single-Cell DNA Methylation + RNA Multi-Omics solution enables simultaneous high-throughput profiling of RNA transcriptomes, immune repertoires (TCR/BCR), and genome-wide DNA methylation (5mC/5hmC) from the same cell. By linking transcriptional and epigenetic information, the platform helps researchers better characterize cellular identity, regulatory states, and disease mechanisms.

The system is designed for scalable studies and is compatible with fresh or frozen tissues as well as single-cell and single-nucleus workflows, making it well suited for population-scale atlas initiatives.

 

Enabling broader access through platform standardization

 

SeekGene’s technology strategy centers on a modular platform architecture that allows diverse transcriptomic epigenomic, and spatial single-cell workflows to run on the same instrument. This unified design allows research teams to adopt different assay types without switching hardware, simplifying implementation and lowering operational barriers for large-scale atlas studies.

 

“By joining the HCA program, we hope to make advanced single-cell multi-omics more accessible to researchers worldwide,” said Zongwen, CEO of SeekGene. “Our goal is to democratize these technologies and support the global effort to build high-resolution maps of human biology.”

 

About SeekGene

 

SeekGene is a high-tech enterprise dedicated to developing and democratizing innovative single-cell technologies. Its core strategy, “All In One Cell”, enables multi-omics analysis from a single cell, supported by a comprehensive portfolio of over ten research kits for spatial transcriptomics and epigenetics. This establishes a complete technological loop from sample processing to data analysis. SeekGene's platforms serve over 1,000 research institutions globally, with supporting studies published in top-tier journals such as Cell, Science, and Nature. The company is committed to its vision of "driving innovation through technology and decoding the unknowns of life," striving to be a trusted partner in pioneering single-cell research. 

 

About the Human Cell Atlas

 

The Human Cell Atlas (HCA) is an international collaborative consortium whose mission is to create comprehensive reference maps of all human cells—the fundamental units of life—as a basis for understanding human health and for diagnosing, monitoring, and treating disease. The HCA community is producing high quality Atlases of tissues, organs and systems, to create a milestone Atlas of the human body. More than 3,500 HCA members from over 100 countries are working together to achieve a diverse and accessible Atlas to benefit humanity across the world.  

Discoveries are already informing medical applications from diagnoses to drug discovery, and the Human Cell Atlas will impact every aspect of biology and healthcare, ultimately leading to a new era of precision medicine.

 

For More Information

 

For information about HCA member discounts and SeekGene single-cell solutions, visit www.seekgene.com or contact info@seekgene.com.

attachment: